Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2294 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Medtronic completes acquisition of CoreValve

Medtronic has also recently acquired Ventor Technologies, a developer of percutaneous, catheter-based transapical aortic valve replacement products. Bill Hawkins, chairman and CEO of Medtronic, said: “These acquisitions position

Natco and Lupin to sell generic kidney drug

Lanthanum carbonate tablets are used in cases of kidney failure and would facilitate phosphate absorption. Lanthanum carbonate tablets are sold under the brand name of Fosrenol by the

Auspex makes senior management changes

Most recently, Dr Newbold was senior vice president of business development at Celldex Therapeutics. Dr Newbold holds an MBA from Columbia University and received his PhD in organic

TcLand Expression names new board member

Mr Terry is the co-founder and former director at Genomic Health, a personalized medicine company. He is also a founder of the Personalized Medicine Coalition, and co-founder and

Cardiola raises $2 million in financing

The proceeds are being used to commercialize in Europe the company’s patented m.pulse device designed to treat chronic heart failure (CHF), non-surgically, in a patient’s home. Cardiola’s m.pulse

SpineGuard raises $11 million in financing

The company has used part of the proceeds to acquire the PediGuard unit from SpineVision. SpineGuard was advised on both transactions by Aelios Finance. Ms Bette, chief technology